SCHEMBL20438643

SCHEMBL20438643

CC(C)CCNC(=O)CCS

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
PKM P14618 1/20 0.50
CNR1 P21554 1/20 0.47
HPGD P15428 1/20 0.47
NAMPT P43490 2/20 0.44
POLB P06746 2/20 0.44
HTT P42858 1/20 0.44
ANPEP P15144 3/20 0.42
RNPEP Q9H4A4 2/20 0.42
DNPEP Q9ULA0 2/20 0.42
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 2/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257878 0.87 ALDH1A1 (0.58) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL17123488 0.86 ALDH1A1 (0.46) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL11452609 0.85 ALDH1A1 (0.61) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL20203519 0.83 LMNA (0.45) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL13328249 0.81 LMNA (0.60) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL26733411 0.81 ALDH1A1 (0.52) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL25746265 0.81 ALDH1A1 (0.57) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL8847608 0.81 CNR1 (0.57) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL26930665 0.80 LMNA (0.47) ALDH1A1LMNAPKMCNR1HPGD
SCHEMBL23395460 0.79 LMNA (0.48) ALDH1A1LMNAPKMCNR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 ALDH1A1 787/4885LMNA 3900/4885PKM 2147/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 ALDH1A1 1061/4885LMNA 3842/4885PKM 2617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.